Navigation Links
Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
Date:2/21/2008

are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning new products, potential regulatory approvals, customer adoption and potential milestone payments are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to: (i) the risk that new products, including the PROCLEIX ULTRIO assay, will not be cleared for marketing in the timeframes we expect, if at all, (ii) the risk that we may not earn or receive milestone payments from our collaborators, (iii) the possibility that the market for the sale of our new products, such as our PROCLEIX ULTRIO assay and PROCLEIX TIGRIS system, may not develop as expected, (iv) we may not be able to compete effectively, (v) we may not be able to maintain our current corporate collaborations and enter into new corporate collaborations or customer contracts, and (vi) we are dependent on Novartis and other third parties for the distribution of some of our products. The foregoing describes some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update any forward-looking sta
'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
2. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
3. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
8. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
9. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
10. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
11. EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015 Un fournisseur mondial ... sont l,hypertension, le diabète et les troubles thyroïdiens ... gratuites et d,une conférence majeure dédiée à ces ... ) , Les formations Prendre ... Prendre en charge l,hypertension en ligne et ...
(Date:7/2/2015)... , July 3, 2015 ... adquisición del 100% de participación en ZAO "Biocom" ... adquisición marca la incursión de Lupin en el ... de RUB en ventas, colocándolo como uno de ... 2014 (IMS Health). Durante más de una década, ...
(Date:7/2/2015)... N.C. , July 2, 2015  New product ... of its leading role in educating thought leaders about ... that can heavily influence how well a new therapy ... new study from research and consulting leader Best Practices, ... leaders need to focus on are early stage thought ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... 13 Luminous Medical, Inc. announced today that it ... sensors for exclusive rights to incorporate its glucose sensor ... developing its monitor to enable clinicians to control hyperglycemia ... Luminous was planning to use a sensing technology based ...
... Oct. 13 CeloNova BioSciences, Inc. has received ... Standards Institution, to expand the list of medical ... and to add a tenth size of the ... ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b ) ...
Cached Medicine Technology:Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 2Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 2Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 3
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency ... named Mariah N. Manzanares, MD as the new Medical Director of its Frisco facility. ... director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a ... those of celebrities will have the opportunity to get 10% discount on orders that ... people do not have to use coupon codes or remember redemption codes. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by JAMA Internal ... outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity in the ... now," Becic said. "We must understand the magnitude of this discovery. For that reason, ...
(Date:7/2/2015)... Vancouver, BC (PRWEB) , ... July 02, 2015 , ... With summer in full swing, ... , Canada is one of the top spots for fishing in the world, and it’s ... and rivers of Ontario, Canada has great fish. , Recreational fishing is a huge ...
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, ... ... or field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the ... physicians, fitness experts and athletic trainers. Their significant popularity has inspired four new, ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... whose parents have high expectations for their ability to ... other children dealing with the condition, according to a ... asthma controller medications appropriately if they have a routine ... how well symptoms can be controlled. , The study, ...
... many calories they are actually consuming, which can hinder ... person would overestimate the amount of exercise they,re doing, ... a study to be presented at The Obesity Society,s ... a Lead Health Services Specialist at Temple,s Center for ...
... Food and Drug,Administration (FDA) reopened discussions on ... dispensing decongestants, antihistamines and cough,suppressants to children, ... the,estimated benefits for children based on using ... in adults., (Photo: http://www.newscom.com/cgi-bin/prnh/20081003/NEF040-a ...
... Discrimination; Recognizes,Importance of Mental Health to Overall ... Mental Health,America today hailed as "a great ... health parity legislation that will broadly outlaw ... and substance-use,conditions in employer-sponsored health plans., ...
... As the population ages, a big,question employers must start asking ... In most cases the answer is no. 95% of ... provide for their families. What,happens when one of the spouses ... drops for the person that is sick but the healthy,employee/spouse ...
... General surgeon salary survey shows 40 percent imagine negative income impact. ... ... Although the economy currently dominates both the news media and the ... for the new president, according to recent survey results. But how ...
Cached Medicine News:Health News:Children's asthma affected by parental expectations 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 2Health News:Safe New Children's Medicines Launched for Cough, Cold and Flu Season 3Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 2Health News:LocumTenens.com Reaps Mixed Reviews on Universal Healthcare 3
... Depth Perception. Test and Evaluate,Both Gross ... and Fine Depth Perception., ,The Test ... 40 sec of arc), Animal Test ... of arc), 1 Pair of Standard ...
... Emit 2000 Phenytoin Assay is ... for use in the quantitative ... serum or plasma. Kits are ... the Roche COBAS MIRA, COBAS ...
... Digoxin Assay is a homogeneous ... in the quantitative analysis of ... plasma. Kits are packaged specifically ... COBAS MIRA, COBAS MIRA S, ...
For the qualitative and semi-quantitative measurement of RF in human serum....
Medicine Products: